Glaukos Corporation (Glaukos) is an ophthalmic medical device company. The company researches and develops micro technologies to improve glaucoma therapy. Its product portfolio includes microstent devices to treat glaucoma such as iStent Trabecular Micro-Bypass stent for the treatment of mild- tomoderate open-angle glaucoma. Glaukos iStent is used in conjunction with cataract surgery. The companys micro-bypass devices are validated by clinical, in vitro, and fluid mechanics research. It markets its products through a network of distributors in Canada, France, Germany, Italy, Portugal, Spain and the United Kingdom. Glaukos is headquartered in Orange County, California, the US._x005F_x000D_

This report is a source for data, analysis and actionable intelligence on the Glaukos Corporation portfolio of pipeline products. The report provides detailed analysis on each pipeline product with information on the indication, the development stage, trial phase, product milestones, pipeline territory, estimated approval date, and estimated launch date.

Each pipeline product is profiled to cover information on product description, function, technology, indication, and application. The report is also supplemented with a detailed company profile and information on clinical trials, wherever applicable.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by team of industry experts.